primary or metastatic lung tumors: Proof of principle using dogs with spontaneously occurring tumors as a model. Clin Cancer Res 5:2653–2659.289 Hershey, A.E., K.U. Sorenmo, M.J. Hendrick, et al. 2000. Prognosis for presumed feline vaccine‐associated sarcoma after excision: 61 cases (1986–1996). J Am Vet Med Assoc 216:58–61.
290 Higginbotham, M.L., D.L. McCaw, J.K. Roush, et al. 2013. Intermittent single‐agent doxorubicin for the treatment of canine B‐cell lymphoma. J Am Anim Hosp Assoc 49:357–362.
291 Higgs, P. and A. Hibbert. 2012. Managing hyperthyroidism in cats. Vet Rec 171:225–226.
292 Higuchi, T., G.N. Burcham, M.O. Childress, et al. 2013. Characterization and treatment of transitional cell carcinoma of the abdominal wall in dogs: 24 cases (1985–2010). J Am Vet Med Assoc 242:499–506.
293 Higuchi, T., N. Dervisis, and B.E. Kitchell. 2010. Efficacy of doxorubicin for histiocytic sarcoma in dogs. In Proceedings of the Veterinary Cancer Society, 30th Annual Conference. San Diego, USA, October 29–November 1, 2010, p. 51.
294 Hill, K.E., J.P. Chambers, B.R. Jones, et al. 2015a. Regional variations in percutaneous absorption of methimazole: An in vitro study on cat skin. J Vet Pharmacol Ther 38:616–618.
295 Hill, K.E., J.P. Chambers, B.R. Jones, et al. 2015b. Trans‐pinnal movement of methimazole: An in vitro study showing that methimazole can cross from the inner to outer pinna of cats. J Feline Med Surg 17:1005–1011.
296 Hill, K.E., M.A. Gieseg, D. Kingsbury, et al. 2011. The efficacy and safety of a novel lipophilic formulation of methimazole for the once daily transdermal treatment of cats with hyperthyroidism. J Vet Intern Med 25:1357–1365.
297 Hill, K.E., P.C. Mills, B.R. Jones, et al. 2015c. Percutaneous absorption of methimazole: An in vitro study of the absorption pharmacokinetics for two different vehicles. J Vet Pharmacol Ther 38:581–589.
298 Hillers, K.R., S.E. Lana, C.R. Fuller, et al. 2007. Effects of palliative radiation therapy on nonsplenic hemangiosarcoma in dogs. J Am Anim Hosp Assoc 43:187–192.
299 Hitt, M.E., D.P. Shaw, P.M. Hogan, et al. 1987. Radiation treatment for thymoma in a dog. J Am Vet Med Assoc 190:1187–1190.
300 Hobson, H.P., M.R. Brown, and K.S. Rogers. 2006. Surgery of metastatic anal sac adenocarcinoma in five dogs. Vet Surg 35:267–270.
301 Hodge, S.C., D. Degner, R. Walshaw, et al. 2011. Vascularized ulnar bone grafts for limb‐sparing surgery for the treatment of distal radial osteosarcoma. J Am Anim Hosp Assoc 47:98–111.
302 Hoelzler, M.G., J.R. Bellah, and M.C. Donofro. 2001. Omentalization of cystic sublumbar lymph node metastases for long‐term palliation of tenesmus and dysuria in a dog with anal sac adenocarcinoma. J Am Vet Med Assoc 219:1729–1731, 1708.
303 Hoffman, S.B., A.R. Yoder, and L.A. Trepanier. 2002. Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats. J Vet Pharmacol Ther 25:189–193.
304 Hoffmann, G., S.L. Marks, J. Taboada, et al. 2003. Transdermal methimazole treatment in cats with hyperthyroidism. J Feline Med Surg 5:77–82.
305 Hogge, G.S., J.K. Burkholder, J. Culp, et al. 1999. Preclinical development of human granulocyte‐macrophage colony‐stimulating factor‐transfected melanoma cell vaccine using established canine cell lines and normal dogs. Cancer Gene Ther 6:26–36.
306 Holt, P.E. 2007. Evaluation of transanal endoscopic treatment of benign canine rectal neoplasia. J Small Anim Pract 48:17–25.
307 Holt, P.E. and P. Durdey. 1999. Transanal endoscopic treatment of benign canine rectal tumours: Preliminary results in six cases (1992 to 1996). J Small Anim Pract 40:423–427.
308 Holtermann, N., M. Kiupel, M. Kessler, et al. 2016. Masitinib monotherapy in canine epitheliotropic lymphoma. Vet Comp Oncol 14 (Suppl 1):127–135.
309 Huber, D.J., S.J. Withrow, S.M. Larue, et al. 2000. Limb sparing with intraoperative radiation for bone sarcomas. Vet Surg 29:446–456.
310 Hui, T.Y., D.S. Bruyette, G.E. Moore, et al. 2015. Effect of feeding an iodine‐restricted diet in cats with spontaneous hyperthyroidism. J Vet Intern Med 29:1063–1068.
311 Hunley, D.W., G.N. Mauldin, K. Shiomitsu, et al. 2010. Clinical outcome in dogs with nasal tumors treated with intensity‐modulated radiation therapy. Can Vet J 51:293–300.
312 Irvine‐Smith, G.S. and R.G. Lobetti. 2006. Ipsilateral vascularised ulnar transposition autograft for limb‐sparing surgery of the distal radius in 2 dogs with osteosarcoma. J S Afr Vet Assoc 77:150–154.
313 Isidoro‐Ayza, M., A. Lloret, M. Bardagi, et al. 2014. Superficial necrolytic dermatitis in a dog with an insulin‐producing pancreatic islet cell carcinoma. Vet Pathol 51:805–808.
314 Itoh, T., K. Mikawa, M. Mikawa, et al. 2004. Lymphangiosarcoma in a dog treated with surgery and chemotherapy. J Vet Med Sci 66:197–199.
315 Itoh, H., T. Mukaiyama, T. Goto, et al. 2014. Non‐surgical treatment of canine oral malignant melanoma: A case study of the application of complementary alternative medicine. Oncol Lett 7:1829–1830.
316 Jackson, J., K.P. Richter, and D.P. Launer. 1999. Thoracoscopic partial pericardiectomy in 13 dogs. J Vet Intern Med 13:529–533.
317 Jacobs, T.M. and G.M. Rosen. 2000. Photodynamic therapy as a treatment for esophageal squamous cell carcinoma in a dog. J Am Anim Hosp Assoc 36:257–261.
318 Jeglum, K.A. 1996. Chemoimmunotherapy of canine lymphoma with adjuvant canine monoclonal antibody 231. Vet Clin North Am Small Anim Pract 26:73–85.
319 Jeglum, K.A., A. Whereat, and K. Young. 1983. Chemotherapy of canine thyroid carcinoma. Compend Contin Educ Pract Vet 5:96–98.
320 Jeglum, K.A., K.M. Young, K. Barnsley, et al. 1988. Chemotherapy versus chemotherapy with intralymphatic tumor cell vaccine in canine lymphoma. Cancer 61:2042–2050.
321 Jourdier, T.M., C. Moste, M.C. Bonnet, et al. 2003. Local immunotherapy of spontaneous feline fibrosarcomas using recombinant poxviruses expressing interleukin 2 (IL2). Gene Ther 10:2126–2132.
322 Kahn, S.A., C.M. Mullin, L.P. De Lorimier, et al. 2013. Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: A pilot study. Can Vet J 54:237–242.
323 Kane, R.C., W.D. McGuinnJr., R. Dagher, et al. 2008. Dexrazoxane (Totect): FDA review and approval for the treatment of accidental extravasation following intravenous anthracycline chemotherapy. Oncologist 13:445–450.
324 Karayannopoulou, M., E. Kaldrymidou, T.C. Constantinidis, et al. 2001. Adjuvant post‐operative chemotherapy in bitches with mammary cancer. J Vet Med A Physiol Pathol Clin Med 48:85–96.
325 Kaser‐Hotz, B., C.R. Rohrer, J.L. Fidel, et al. 2001. Radiotherapy in three suspect cases of feline thymoma. J Am Anim Hosp Assoc 37:483–488.
326 Kawabe, M., T. Mori, Y. Ito, et al. 2015. Outcomes of dogs undergoing radiotherapy for treatment of oral malignant melanoma: 111 cases (2006–2012). J Am Vet Med Assoc 247:1146–1153.
327 Keller, E.T., E.G. MacEwen, R.C. Rosenthal, et al. 1993. Evaluation of prognostic factors and sequential combination chemotherapy with doxorubicin for canine lymphoma. J Vet Intern Med 7:289–295.
328 Kent,
